Abacavir and Lamivudine (Prasco Laboratories)
Welcome to the PulseAid listing for the Abacavir and Lamivudine drug offered from Prasco Laboratories. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Prasco Laboratories |
NON-PROPRIETARY NAME: | abacavir sulfate and lamivudine |
SUBSTANCE NAME: | ABACAVIR SULFATE; LAMIVUDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2016-09-29 |
END MARKETING DATE: | 0000-00-00 |
Abacavir and Lamivudine HUMAN PRESCRIPTION DRUG Details:
Item Description | Abacavir and Lamivudine from Prasco Laboratories |
LABELER NAME: | Prasco Laboratories |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 600; 300(mg/1; mg/1) |
START MARKETING DATE: | 2016-09-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 66993-482_704acc32-038d-4b75-907d-96e4f5839ea4 |
PRODUCT NDC: | 66993-482 |
APPLICATION NUMBER: | NDA021652 |
Other ABACAVIR SULFATE; LAMIVUDINE Pharmaceutical Manufacturers / Labelers: